22nd April 2015: Sphere Fluidics Wins CorporateLiveWire Award Innovation and Excellence Award
Sphere Fluidics has won a CorporateLiveWire 2015 award for Innovation and Excellence in Life Sciences Products and Services. "We are very pleased that Sphere Fluidics has been recognised for our innovative attitude in developing novel products and services", said Dr Frank F. Craig (CEO). "The award further strengthens our aims to be successful in Life Sciences markets". Award information can be found on page 96 here: www.corporatelivewire.com/Awards/InnovationExcellence2015/flipviewerxpress.html
17th April 2015: Sphere Fluidics Wins Investors In People Accreditation
Sphere Fluidics has been awarded Investors in People (IIP) Accreditation. "IIP is a management framework for achieving high performance through people", said Dr Frank F. Craig (CEO). "Sphere Fluidics takes great care to align its people with our business strategy, ensure that our staff are well-trained, and given opportunities to improve themselves and the business. The IIP award reflects our success in this approach". IIP information can be found here: www.investorsinpeople.co.uk/about
8th April 2015: Sphere Fluidics Presenting Poster at Proteins and Antibodies Congress
Tara-Jane Bloomfield-Gerdes (Associate Scientist) will be representing Sphere Fluidics at this year’s Annual Proteins & Antibodies Congress with a poster presentation. The poster is titled ‘Enhancing Monoclonal Antibody Production with Picodroplet Technology’. “I am very excited to have been given the opportunity to present our technology which could revolutionise the biopharmaceutical industry”, said Tara-Jane Bloomfield-Gerdes. “The Proteins & Antibodies Congress will be an excellent place to meet like-minded people, and hopefully create relationships for future collaborations.” The 8th Annual Proteins & Antibodies Congress will take place in London, UK from the 20th-21st April 2015. More information can be found at: www.proteins-congress.com
26th March 2015: Sphere Fluidics Awarded Almost £1.6 million in AMSCI Biologics Manufacturing Grant
Sphere Fluidics has won £1.6 million of a BIS £6.2 million Advanced Manufacturing Supply Chain Initative grant. The grant was led by the Centre for Process Innovation and other syndicate members included UCB, Lonza, Horizon Discovery and Alcyomics. "I am very pleased to win this grant", said Dr Marian Rehak (R&D Director of Sphere Fluidics). "The syndicate aims to incorporate Sphere Fluidics' Cyto-Mine platform into the biologics supply chain and revolutionise it.". Other information can be found here: www.uk-cpi.com/news/cpi-led-uk-biotech-consortium-secures-6-2m-government-investment/
17th March 2015: Sphere Fluidics a Finalist in Business Weekly Life Sciences Innovation Award
Sphere Fluidics has been nominated as a finalist in the East of England's Business Weekly 2015 Life Sciences Innovation Award. "I am very pleased that our innovative, single cell analysis platform has been recognised in the biotech community" said Dr Rob Marchmont (Commercial Director). "AstraZeneca and MedImmune sponsored the award and Sphere Fluidics is a member of an exciting group of finalists".
16th March 2015: Sphere Fluidics Pitches to Investors at Cambridge Enterprise Venture Partners Event
Sphere Fluidics' CEO (Dr Frank F.Craig) will be pitching to a room of circa 50 investors at the Cambridge Enterprise Venture Partners dinner at Christ College, Cambridge (UK) on 17th March 2015. "I will be reviewing the significant commercial progress we are now experiencing plus outlining the Cyto-Mine program and the major new markets that we have identified to our current (and potentially new) investors. This marks the start of an exciting year of accelerated growth for Sphere Fluidics".
12th March 2015: Sphere Fluidics Files Cyto-MIne for a US Trademark
Sphere Fluidics has submitted theTrademark for Cyto-Mine for filing in the US. Cyto-Mine is a novel single cell assay and monoclonality assurance system. "Cyto-Mine is creating a lot of excitement in the industry and the US is our biggest market. Thus, it is important for us to get IP protection in that region" said Dr Frank F. Craig (CEO). "We aim to have the trademark awarded late this year".
7th March 2015: Sphere Fluidics Exhibiting at Bio-Europe 2015 in Paris
Dr Rob Marchmont (Commercial Director) and Dr Frank F. Craig (CEO) will be attending Bio-Europe Spring 2015 in Paris (France) on March 9th-11th 2015. "We will be exhibiting at the UK Pavilion and also attending a number of biopartnering meetings with leading companies." said Dr Marchmont. "Bio-Europe is a great conference and I look forward to meeting key companies and establishing new collaborations at the meeting." said Dr Craig. Bio-Europe conference information can be found here: www.ebdgroup.com/bes/index.php
5th March 2015. Sphere Fluidics Named as one of the UK's Top Disruptive SMEs
Sphere Fluidics has been nominated by Real Business as one of the UK's Top 50 Disruptive SMEs. This was part of the Everline Future 50 competition. Dr Rob Marchmont (Commercial Director) attended the awards ceremony and stated "It is great news that Cyto-Mine and our single cell analysis technology has been recognised by the broader UK business community as revolutionary". Information on the award can be found here: realbusiness.co.uk/article/29477-sphere-fluidics-single-cell-analysis-has-never-looked-so-disruptive_29477
28th February 2015: Sphere Fluidics to Present at Biopharmaceutical Symposium
Sphere Fluidics' CEO (Dr Frank F. Craig) will be presenting at a KTN Biopharmaceutical Analytical Group Symposium to be held in Leeds (UK) on the 4th-5th of March 2015. The title of his talk will be: "Cyto-Mine Single Cell Analysis Technology for Accelerated Biopharmaceutical Discovery and Development". He said, "This is an excellent forum that brings together leaders in the biopharmaceutical discovery and tools field. I will present on progress of Cyto-Mine development and use of picodroplets with single cells". Conference information can be found here: www.enterpriseeuropeeast.org.uk/eox/events/register.as
10th February 2015: Sphere Fluidics Attending The Royal Society's "Labs to Riches" Event in London
Sphere Fluidics' CEO (Dr Frank F. Craig) will be attending The Royal Society's prestigious "Labs to Riches" event in London on the 11th Feb 2015. "This is an annual event where science, business ands society leaders get together for annual awards and networking. It is an excellent forum for showcasing science, new companies and bringing together companies with potential investors. I look forward to interesting discussions", he said. More information can be found here: royalsociety.org/grants/labs-to-riches/
21st January 2015: Sphere Fluidics attending Industrial Biotechnology Showcase 2015 in London
Dr Frank F. Craig (CEO of Sphere Fluidics Limited) will be attending the InnovateUK network conference on Industrial Biotechnology on Feb 11th-12th 2015 in London. "This is an excellent forum for industry and academia to get together and share thoughts on industrialising technology for (bio)pharmaceutical manufacture, enzyme production and bioprocessing etc. Our new single cell analysis platform (Cyto-Mine) will have a large impact on such areas as well as upstream in discovery and development. I am also looking forward to meeting with other industry colleagues at the biopartnering aspect at the conference". Conference information can be found here: connect.innovateuk.org/web/industrial-biotechnology